Citigroup Maintains Buy on Wave Life Sciences, Lowers Price Target to $15
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Citigroup analyst Samantha Semenkow maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $19 to $15.
Citigroup analyst Samantha Semenkow maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $19 to $15.